Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...
Monica M. Bertagnolli, MD, FACS, FASCO, and W. Kimryn Rathmell, MD, PhD, have stepped down as directors of the NIH and NCI as ...
Cancellations of NIH grant review panels, in particular, could affect cancer research grants and funding. In these NIH grant ...
A temporary freeze on meetings on the National Institutes of Health could lead to delays in disbursing research grants and in approving crucial clinical trials.
Just days after President Trump imposed broad restrictions on communications, meetings, travel and public appearances at the ...
The agency expects “additional guidance” this week on the communications freeze — which unleashed confusion about whether ...
A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research and the like.
A flurry of scientific gatherings and panels across federal science agencies were canceled on Wednesday, at a time of heightened sensitivity about how the Trump administration will shift the agencies’ ...
Following President Trump’s inauguration, the flurry of executive orders and funding freezes introduced uncertainty into the ...
About CTT Pharmaceuticals Holdings, Inc. CTT has patented technology in The United States, Europe, Canada and many additional countries to allow many actives on a dissolvable strip that include but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback